Loading MIR detail
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, and Japan.
It operates through two segments, Medical and Industrial. The medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Industrial segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006.
Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Chart data unavailable

Mirion Technologies (NYSE: MIR - Get Free Report) and Nextech3D.AI (OTCMKTS:NEXCF - Get Free Report) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk. Profitability This table compares Mirion Technologies and Nextech3D.AI's

Bamco Inc. NY acquired a new stake in shares of Mirion Technologies, Inc. (NYSE: MIR) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 500,000 shares of the company's stock, valued at approximately $11,630,000. Bamco Inc. NY owned 0.20% of Mirion Technologies

Victory Capital Management Inc. grew its position in shares of Mirion Technologies, Inc. (NYSE: MIR) by 12.9% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,082,626 shares of the company's stock after buying an additional 123,952 shares during the quarter. Victory

CI Investments Inc. lifted its position in shares of Mirion Technologies, Inc. (NYSE: MIR) by 82.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 96,565 shares of the company's stock after purchasing an additional 43,700 shares during the quarter. CI Investments Inc.'s

Citigroup Inc. boosted its position in Mirion Technologies, Inc. (NYSE: MIR) by 86.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 480,372 shares of the company's stock after buying an additional 223,271 shares during the quarter. Citigroup Inc. owned approximately 0.21%

Rhumbline Advisers grew its holdings in Mirion Technologies, Inc. (NYSE: MIR) by 91.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 608,834 shares of the company's stock after acquiring an additional 290,232 shares during the period.

Mirion Technologies, Inc. (MIR) Presents at Citi's Global Industrial Tech & Mobility Conference 2026 Transcript

Insight into Leon Cooperman (Trades, Portfolio)'s Fourth Quarter 2025 13F Filing Leon Cooperman (Trades, Portfolio) recently submitted the 13F filing for the f

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that Chairman and Chief Executive Officer, Thomas Logan, and Chief Financial Officer and Medical Group President, Brian Schopfer, will present at Citi's 2026 Global Industrial Tech and Mobility Conference. The presentation will begin at 2:40 PM ET on Wednesday, February 18, 2026. The presentation will be webcast live at Mirion's Investor Relations Page where a webcast link will be displayed under the "Events and Presentations” section.

Mirion Technologies, Inc. (MIR) Q4 2025 Earnings Call Transcript

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR), a global leader in radiation detection, measurement, analysis and monitoring solutions for the nuclear, medical, defense and research end markets, today announced three new leadership appointments supporting the company's continued focus on safety, innovation, operational excellence and long-term growth. Chief Nuclear Officer: Tighe Smith Mirion has promoted Tighe Smith to the newly created role of Chief Nuclear Officer. Reporting to Thomas Logan, M.

Mirion Technologies, Inc. (MIR) came out with quarterly earnings of $0.15 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.17 per share a year ago.

ATLANTA--(BUSINESS WIRE)--Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced results for the fourth quarter and full year ended December 31, 2025. “Mirion concluded another successful year, highlighted by record orders, strong tailwinds from key strategic end-markets, and a broadening nuclear power portfolio,” commented Mirion's Chairman.

Thrivent Financial for Lutherans acquired a new position in Mirion Technologies, Inc. (NYSE: MIR) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 179,781 shares of the company's stock, valued at approximately $4,182,000. Thrivent Financial for Lutherans owned approximately 0.08%

Mirion Technologies (MIR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.